CASTRATION-RESISTANT PROSTATIC CANCER
Clinical trials for CASTRATION-RESISTANT PROSTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATIC CANCER trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested to stall advanced prostate cancer
Disease control OngoingThis study is testing whether adding a drug called niraparib to a standard treatment (abiraterone acetate plus prednisone) works better than the standard treatment alone for men with advanced prostate cancer that has spread. It aims to see if the combination can delay the cancer …
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Brain scans reveal hidden side effects of prostate cancer drugs
Knowledge-focused OngoingThis study investigates whether two common prostate cancer drugs (abiraterone acetate and enzalutamide) affect thinking, memory, and brain function. Researchers are following 100 men with advanced prostate cancer, using brain scans and cognitive tests to measure changes over time…
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE4 • Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC